Pick of the Day · October 1, 2026
As of close 2026-10-01

CBLL

CeriBell, Inc.SQUEEZE PLAY setup

Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.

Entry Price
$23.61
Total Return
+0.00%
vs SPY
+0.00%
Current Price
$23.61
The 7-Day Frame
7 days
A tactical idea measured against the S&P 500 at the 7-day mark.
See the track record →
Key Takeaways
  • CeriBell, Inc. (CBLL) is the Signal52 Pick of the Day for 2026-10-01.
  • Framed as a 7-day tactical idea: performance is measured against the S&P 500 at the 7-day mark.
  • Setup type: squeeze play.
  • Selection is as of the 2026-10-01 market close; performance is tracked on the public track record.

Executive Summary

Ceribell (CBLL) has just secured a highly material FDA 510(k) clearance for its new EEG software, instantly removing regulatory overhang and providing an immediate commercialization catalyst. In the current Risk-On, earnings-driven market environment, high-beta medical technology names with concrete regulatory wins are being aggressively rewarded by capital allocators. With the stock coiled tightly in a Bollinger Squeeze, this fundamental catalyst serves as the perfect ignition switch for a momentum breakout.

Technical Context
The Setup

Trading just 5.7% below its 52-week high with a Perfect Stack signal and volume compressing at 0.9x its 20-day average, CBLL is a coiled spring primed for explosive expansion.

Setup profileSQUEEZE PLAYWhat these mean →
Invalidation — what would prove this wrong
The bullish thesis is invalidated if CBLL breaks and closes below the established support level of $23.43 on expanding volume.
Runner-ups — considered, not selected
BIIB

Strong earnings and pipeline momentum, but catalyst is 48h old and slightly stale compared to fresh FDA news

AAMI

Exceptional technical confluence (6.2 score) but lacks a specific, high-materiality catalyst

BFLY

Fresh Strong-Buy upgrade from Evercore, but technicals are less coiled than CBLL

BUUU

Highly material 40MW AI data center deal, but extremely low relative volume (0.1x) presents liquidity risk

Recent Performance History · 153 total picks · 48% win rate (7d) · 44% beat SPY (7d)Full history →
DateTickerEntryLastGain/Loss7d30d60d
2026-09-30ARX$19.73$19.73+0.00%———
2026-09-28CGAU$21.76$21.54-1.01%———
2026-09-25BB$8.21$9.18+11.81%———
2026-09-24BIO$387.54$355.57-8.25%-8.25%——
2026-09-23HAE$106.82$104.37-2.29%-1.42%——
2026-09-22BHE$82.23$84.62+2.91%+1.58%——
2026-09-21WBD$30.80$30.95+0.49%+0.32%——
2026-09-18AES$14.83$14.92+0.61%+0.27%——
2026-09-17ANET$199.53$204.49+2.49%+3.09%——
2026-09-16AXTI$64.30$81.81+27.23%+13.50%——
Schema v1.0 | Pipeline v1.2.0